Mizzou Animal Cancer Care is a new radiation oncology facility in Wentzville, Mo., The University of Missouri College of Veterinary Medicine is establishing the facility in order to bring its educational, research and outreach services directly to the most urbanized region of Missouri. Dr. George Buckaloo, a longtime Independence, Mo., veterinarian and CVM alumnus will operate the referral cancer treatment facility.
The CVM is the only college of veterinary medicine in Missouri and one of 28 veterinary colleges in the United States. Mizzou Animal Cancer Care will provide a next logical step in the development of a nationally and internationally recognized program in radiation oncology that has been emerging at the college during the last 14 years.
A physical presence of the college in Wentzville offers several advantages:
Please free to contact us:
Mizzou Animal Cancer Care is located at 1092 Wentzville Parkway. The facility is well-suited for the proposed function based on its size, layout, zoning, location and accessibility. Mizzou Animal Cancer Care and its board-certified oncologists and radiologists are prepared to offer cutting-edge treatment options for animal cancer patients that will benefit from radiation therapy and potentially new anticancer therapies from the college’s participation in clinical trials. The ability to offer clinical trials at the Wentzville location will elevate the CVM’s status as an important contributor to national cancer research efforts and will provide animal cancer patients access to cutting-edge therapies at a reasonable price.
The physical presence of the CVM in Wentzville will allow the college to provide continuing education and outreach on the benefits and limitations of radiation and other cancer therapy in veterinary patients in the St. Louis region. Increased visibility and integration of the CVM’s programming into the veterinary community of the St. Louis region should increase referrals and help attract financial support for the programming of the college. This physical presence of the CVM in the St. Louis region should result in local practitioners being more likely to refer to the CVM and avail themselves of the CVM’s services.
Mizzou Animal Cancer Care will also serve as a focal point for faculty to present continuing education to practitioners. The facility is expected to be operational in the summer of 2011 and the college should be able to start hosting continuing educational presentations soon after.
The CVM is proposing to provide diagnostic services, radiation therapy and clinical trials that are not currently available in the St. Louis area. The distance from St. Louis to Columbia is a deterrent for some potential clients because they do not want to be separated from their animals for a month or cannot make the drive for recommended therapy several times per week, or, as is needed in some cases, daily. In the current difficult economic climate, companion animal owners are less able to take time off from work to commute for radiation therapy in Columbia, and the cost of transportation is a further deterrent. At Mizzou Animal Cancer Care, radiation therapy is just a short drive from home for animals and their owners.
This new radiation therapy referral service makes the resources of a major research university a convenient option for the St. Louis-area veterinarians to offer when their clients look to them for guidance at this critical time in their pets’ lives.
The facility will also provide an additional teaching laboratory for students. This site will be able to support the educational component of the curriculum directly, and to some extent increase the number of cases in which individual students can be directly involved. The Wentzville location will also augment the clinical residency programs in radiation oncology, medical oncology and radiology.
Dr. George Buckaloo, “Renny” to his family and friends, is a 1972 graduate of the University of Missouri College of Veterinary Medicine. After earning his Doctor of Veterinary Medicine, he began his career at the Care Animal Hospital in Arlington Heights, Ill. In 1976, he returned to Missouri and become first a partner and then the owner of the Crysler Animal Hospital in Independence.
He has been a member of the American Veterinary Medical Association since 1972 and a member of the Missouri Veterinary Medical Association since 1976. He has served on the board of directors for the Missouri Veterinary Medical Foundation since 1988. From 2001 to 2008, he was also on the board of directors for Professional Veterinary Products, a public animal health products distributor owned by 2,100 DVM shareholders. He was elected to represent shareholders in Missouri, Arkansas, Louisiana, Mississippi and Alabama. He served as the chairman of the audit committee from 2004 to 2006, board secretary in 2006, board vice-chairman in 2007 and board chairman in 2008.
He is also active in his community having been on the board of directors for a sheltered workshop for disabled adults since 1999 and volunteering at the Independence Animal Shelter.
Dr. Jim Lattimer received his Doctor of Veterinary Medicine degree from Washington State University in 1975. Following two years in private practice he was accepted into a veterinary radiology residency program at Colorado State University, which he completed in 1980 in combination with a master of science degree in radiological sciences. He also achieved Diplomate status in the American College of Veterinary Radiology in diagnostic radiology that year. In 1996 he was awarded Diplomate status by the ACVR affiliate in radiation oncology. He remains an active member in both of these organizations.
He joined the faculty of the Department of Veterinary Medicine and Surgery at the University of Missouri in August 1980 as a diagnostic and therapeutic radiologist and has continued in that position to this day. He currently holds the rank of associate professor in that department with adjunct status in the Nuclear Sciences and Engineering and Radiopharmaceutical Sciences Institutes. He is an author or co-author on more than 40 refereed publications in the fields of veterinary imaging and radiation therapy. His current research interests lie in the area characterizing beam modifications methods, inhomogeniety effects, and radiopharmaceutical treatment of osteosarcoma and prostate carcinoma. He is a clinical radiologist and radiation oncologist currently serving as director of veterinary radiation oncology and nuclear oncology for MU’s Veterinary Medical Teaching Hospital and the Mizzou Animal Cancer Center as well as consulting radiation oncologist for the Veterinary Teaching Hospital at Kansas State University. Away from work he is an avid proponent of swimming for fitness, an amateur woodworker and a lover of animals in general.
A native of Colorado, Dr. Kim Selting completed her undergraduate and veterinary studies at Colorado State University. Following a one-year rotating small animal internship in medicine and surgery at the Animal Medical Center, she then moved to St. Louis. There, Selting spent one year in emergency work and three years in small animal private practice. She then returned to the Colorado State University Animal Cancer Center to pursue a residency in medical oncology. At the completion of this training, she had earned a master’s degree and was board-certified by the American College of Veterinary Internal Medicine in the specialty of oncology. Selting then joined the faculty at the University of Missouri and has remained there since 2002.
Professional clinical and research interests include biomarkers of cancer and chemotherapy toxicity, novel chemotherapy drugs and treatments, and more recently, inhalant chemotherapy and exhaled breath condensate evaluate in the monitoring and treatment of primary and metastatic lung cancer. Past professional roles include president of the Veterinary Cooperative Oncology Group, member-at-large for the Veterinary Cancer Society, and chair of the Oncology Certifying Examination Committee. She is currently pursuing specialty certification in radiation oncology.
Personal interests include horseback riding, triathlons, and spending time with her three children. She is a self-described food and movie buff.
|Dr. Marcy Hammerle is a relief veterinarian for Mizzou Animal Cancer Care. Dr. Hammerle is a committed veterinarian who works at The Pet Doctor in O'Fallon, MO- an American Animal Hospital Association (AAHA) accredited hospital. In 2011, Dr. Hammerle became a Diplomate of the American Board of Veterinary Practitioners (ABVP) as a specialist in canine and feline medicine. Dr. Hammerle is a 2003 graduate of the University of Missouri College of Veterinary Medicine and is an active member of the Missouri Veterinary Medical Association (MVMA) and the American Association of Human-Animal Bond Veterinarians. Dr. Hammerle lives in St. Charles with her husband Tom, 3 children and a large family of animals, both large and small.|
Stephanie Slakey is the receptionist for Mizzou Animal Cancer Care. An Oklahoma native, she started working in a regular veterinary practice in 2005, and continued when moving to Missouri in 2008. She really enjoys interaction with the clients as well as the patients. She will be the voice you hear on the telephone as well as the first face you see when visiting.
Bridget Weber is the senior veterinary technician at Mizzou Animal Cancer Care. After studying biochemistry at the University of Missouri-St. Louis, she earned an associate’s degree in veterinary technology from Jefferson College in Hillsboro, Mo. With 12 years of experience as a veterinary technician in the St. Louis area, she assists with patient anesthesia, is involved in the clinical trials under way at the MACC, and delivers radiation therapy.
After more than 30 years as the owner of his own veterinary clinic, Dr. George Buckaloo was at a crossroads. He wanted to begin winding down his professional career while freeing some time for some volunteer opportunities. However, he also wanted to ensure that his clients and their pets were in capable, compassionate hands.
Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine, is the principal investigator in a study that examines the efficacy of Attaxol™ in dogs with naturally occurring cancer. Attaxol™ was developed, and is produced, by CritiTech, a Lawrence, Kan. drug development company.